CADL · NASDAQ
Candel Therapeutics (CADL) Stock Price & Fundamentals
Candel Therapeutics (CADL) closed at $475.57 on Oct 9, 2026, up 0.39% from the previous close of $473.73.
Share price, past year
1Y +7.15%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $475.57 |
| Sep 30, 2026 | $465.90 |
| Aug 31, 2026 | $470.36 |
| Jul 31, 2026 | $452.72 |
| Jun 30, 2026 | $446.39 |
| May 29, 2026 | $439.75 |
| Apr 30, 2026 | $419.67 |
| Mar 31, 2026 | $415.54 |
| Feb 27, 2026 | $430.99 |
| Jan 30, 2026 | $406.36 |
| Dec 31, 2025 | $406.20 |
| Nov 28, 2025 | $413.28 |
| Oct 31, 2025 | $449.50 |
Key statistics
- Market cap
- $36.20B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.42
- Revenue (TTM)
- —
- Net income (TTM)
- −$88.53M
- Shares outstanding
- 76.1M
- Dividend yield
- —
- 52-week range
- $396.66 – $478.72
Candel Therapeutics's market cap is $36.20B, based on a share price of $475.57 and 76.1M shares outstanding as of Jun 30, 2026.
Financials
Candel Therapeutics reported revenue of $125.00K for fiscal 2022, unchanged 0.00% from fiscal 2021.
Candel Therapeutics reported a net loss of $38.18M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2022ended Dec 31, 2022 | $125.00K | 0.0% | −$18.79M | −15,035.2% | −$0.65 | −$32.72M |
| FY2021ended Dec 31, 2021 | $125.00K | 0.0% | −$36.12M | −28,899.2% | −$1.91 | −$24.05M |
| FY2020ended Dec 31, 2020 | $125.00K | — | −$17.68M | −14,144.0% | −$1.52 | −$10.55M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2022ended Dec 31, 2022 | $32.00K | — | — |
| Q3 FY2022ended Sep 30, 2022 | $31.00K | — | — |
| Q2 FY2022ended Jun 30, 2022 | $31.00K | — | — |
| Q1 FY2022ended Mar 31, 2022 | $31.00K | — | — |
| Q4 FY2021ended Dec 31, 2021 | $32.00K | — | — |
| Q3 FY2021ended Sep 30, 2021 | $31.00K | — | — |
| Q2 FY2021ended Jun 30, 2021 | $31.00K | — | — |
| Q1 FY2021ended Mar 31, 2021 | $31.00K | — | — |
Company profile
- Name
- Candel Therapeutics, Inc.
- Ticker
- CADL
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 117 Kendrick Street, Suite 450, Needham, MA 02494
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001841387
Recent SEC filings
- Sep 10, 2026
- Sep 9, 2026
- Aug 13, 2026
- Aug 13, 2026
- Jun 24, 2026
- Jun 16, 2026
- May 15, 2026
- May 14, 2026
Frequently asked questions
What is Candel Therapeutics's stock price?
Candel Therapeutics (CADL) closed at $475.57 on Oct 9, 2026, up 0.39% from the previous close of $473.73.
What is Candel Therapeutics's market cap?
Candel Therapeutics's market cap is $36.20B, based on a share price of $475.57 and 76.1M shares outstanding as of Jun 30, 2026.
How much revenue does Candel Therapeutics make?
Candel Therapeutics reported revenue of $125.00K for fiscal 2022, unchanged 0.00% from fiscal 2021.
Does Candel Therapeutics pay a dividend?
Candel Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Candel Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures